20.12.2021 SHOP APOTHEKE EUROPE N.V.  NL0012044747

DGAP-News: MedApp Starts Co-operation with Dutch Health Insurer VGZ.


 

DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Miscellaneous
MedApp Starts Co-operation with Dutch Health Insurer VGZ.

20.12.2021 / 10:10
The issuer is solely responsible for the content of this announcement.


Sevenum / Eindhoven, 20 December 2021 - MedApp, the leading app-focused pharmacy in the Netherlands, which is part of SHOP APOTHEKE EUROPE since early 2021, entered into a co-operation with the Dutch health insurance company VGZ. The goal is to help patients dealing with their medication.

VGZ will inform their customers about MedApp's online medication management services as an important tool to improve patient health. MedApp users can set smart medication alerts, obtain a digital medication overview and get their medication delivered at home. With the app, patients also have access to disease-related information and media, improving medication adherence, convenience and eventually their health. Furthermore, it enhances the conversation between patients and doctors since they get a quick overview of the medications, measurements, and symptoms recorded by their patients. 

Pit Janssen, CEO and founder of MedApp, about this co-operation: "It's great to see that VGZ supports our goal to help patients to take their medications correctly. Together with VGZ, we can help patients with a chronic disease to manage their medication therapy better."

From the very beginning, it has been MedApp's mission to help patients suffering from chronic diseases and to make their lives a little bit easier every day. Therefore, the pharmacy-in-app service has been developed with a strong focus on the individual needs of patients.

Marjo Visser, Chief Health Officer of VGZ, a leading insurance company in the Netherlands with a share well above 20% of the market, about the benefits of the co-operation with MedApp: "This is a very advantageous additional service for our members. The app is especially useful in times of the pandemic, when customers can easily have their medicines delivered to their homes."

Earlier this year, SHOP APOTHEKE EUROPE N.V. acquired MedApp. This enabled SHOP APOTHEKE EUROPE to work together on digital medication management and to access the Dutch market of Rx (prescription medication). The Netherlands is now the second market besides Germany where SHOP APOTHEKE EUROPE offers prescription drugs. SHOP APOTHEKE EUROPE, founded in 2001, gained more than 20 years of experience in being an online pharmacy for Rx, OTC as well as related health and beauty and personal care products.


About SHOP APOTHEKE EUROPE.

SHOP APOTHEKE EUROPE is one of Europe's leading and fastest-growing online pharmacies, currently operating in Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland.

Headquartered in the Dutch logistics centre of Sevenum near Venlo with locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Milan, Lille and Eindhoven, SHOP APOTHEKE EUROPE offers its customers a broad range of more than 100,000 original products at attractive prices: OTC, beauty and personal care products as well as prescription drugs, supplemented by high quality natural food and health products, low carb products and sports nutrition. Currently, more than 7.3 million active customers trust SHOP APOTHEKE EUROPE.

Since safe and reliable pharmaceutical advice are top priorities at SHOP APOTHEKE EUROPE, the e-pharmacy provides comprehensive pharmaceutical consulting services.
In preparation for the introduction of electronic prescriptions in Germany, the company will further improve the customer experience with a focus on disease-specific digital medication management services following the acquisition of SMARTPATIENT in January 2021 and MedApp in March 2021. This is a key part of SHOP APOTHEKE EUROPE's strategy to transform itself from a pure online retailer, into a truly customer-centric e-pharmacy platform.

SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 2016 and is part of the SDAX stock index.

About MedApp.

MedApp was founded 6 years ago in Eindhoven to make life with medicines easier. The company is a unique combination of a tech company and an online pharmacy. MedApp has developed an app that allows a patient to take medicines better and have them delivered to their home for free.

Since 2021, MedApp has been part of SHOP APOTHEKE EUROPE, one of the leading and fastest-growing online pharmacies in Europe.
 


20.12.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: SHOP APOTHEKE EUROPE N.V.
Dirk Hartogweg 14
5928 LV Venlo
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: [email protected]
Internet: www.shop-apotheke-europe.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y07
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1260012

 
End of News DGAP News Service

1260012  20.12.2021 

fncls.ssp?fn=show_t_gif&application_id=1260012&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2016 2017 2018 2019 2020 2021 2022e
Umsatzerlöse1 177,39 283,99 539,71 701,01 968,06 1.060,32 1.270,00
EBITDA1,2 -8,84 -12,14 -15,56 -18,58 15,20 -38,73 -25,00
EBITDA-Marge3 -4,98 -4,27 -2,88 -2,65 1,57 -3,65 -1,97
EBIT1,4 -11,64 -19,20 -28,73 -33,45 -0,87 -65,70 -52,00
EBIT-Marge5 -6,56 -6,76 -5,32 -4,77 -0,09 -6,20 -4,09
Jahresüberschuss1 -18,45 -21,36 -33,61 -36,27 -16,77 -74,19 -57,00
Netto-Marge6 -10,40 -7,52 -6,23 -5,17 -1,73 -7,00 -4,49
Cashflow1,7 -17,21 -23,24 -23,54 -30,37 17,80 11,64 19,00
Ergebnis je Aktie8 -2,03 -2,25 -2,79 -2,78 -1,17 -4,15 -3,00
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2021 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Mazars

INVESTOR-INFORMATIONEN
©boersengefluester.de
Shop Apotheke Europe
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A2AR94 88,000 Halten 1.601,54
KGV 2023e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
110,00 0,00 0,00 -43,56
KBV KCV KUV EV/EBITDA
3,86 137,65 1,51 -34,53
Dividende '20 in € Dividende '21e in € Div.-Rendite '21e
in %
Hauptversammlung
0,00 0,00 0,00 14.04.2022
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
05.05.2022 03.08.2022 31.10.2022 02.03.2022
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
2,70% -19,00% -22,26% -47,12%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu SHOP APOTHEKE EUROPE N.V.  ISIN: NL0012044747 können Sie bei DGAP abrufen


E-Commerce , A2AR94 , SAE , XETR:SAE